This section focuses on recent global studies and discoveries in the various fields of healthcare.
Despite development of effective SARSCoV vaccines a subgroup of vaccine nonresponders depends on therapeutic antibodies or smallmolecule drugs in cases of severe disease
Cardiac device infection CDI can occur in up to of patients after device placement with mortality rates exceeding Although device removal is standard management
Rab GTPases play key roles in controlling intracellular vesicular transport GTPbound Rab proteins support vesicle trafficking Here we report that unlike cellular protein cargos retromermediated delivery of human papillomaviruses
Predicting the duration of ventilation in the ICU helps in assessing the risk of ventilatorinduced lung injury ensuring sufficient oxygenation and optimizing resource allocation
This study determined whether initiation of pharmacologic treatment was delayed for newly diagnosed osteoporosis patients during the COVID pandemic
Dual antiplatelet therapy DAPT following percutaneous coronary intervention PCI reduces major adverse cardiovascular events MACE and stent thrombosis However DAPT duration is a concern in high bleeding risk HBR patients
To evaluate the central venoustoarterial carbon dioxide difference combined with arterialtovenous oxygen content difference PvaCOCavO ratio as a predictor of mortality in patients with COVIDrelated severe acute respiratory distress syndrome ARDS
The COVID pandemic has created an urgency to study the host gene response that leads to variable clinical presentations of the disease particularly the critical illness response miRNAs have been implicated in the mechanism
Nonadherence to medication due to cost is a serious challenge in the US healthcare system as one in four adults in the US have a difficult time affording their medications The COVID pandemic has imposed an unprecedented burden
The objective of this study was to describe the correlation between the commercially available assay for antiSRBD IgG and protective serum neutralizing antibodies nAb against SARSCoV in an adult population after SARSCoV vaccination and determine if clinical variables impact this correlation